Connect with us

News

First hemp wig created for vegan barristers

Published

on

The wigs will be made a legal requirement across all UK courts

The world’s first industrial hemp wig to be manufactured for vegan barristers this year, will see cannabis make its mark in the courtroom.

Vegan Pupil Barrister Samuel March has partnered with hemp textile designer Laura Bossom, to create the first locally made industrial hemp wig.

Set to be manufactured in the UK this year, the wig will be rolled out as legal wear to be worn in courts around the country.

Traditionally, for the past 200 years, barristers have worn wigs made from horsehair, which were first invented in 1822 by Humphrey Ravenscroft.

Photo credit – Chloe Evans

But with vegans and vegetarians set to make up a quarter of the British population by 2025 – and Generation Z (those aged 18 -23) currently the most meat-free generation yet – there is an incoming generation of law students and future barristers whose ethical beliefs prevent them from wearing animal products. 

Previously synthetic wigs had been available to order from Australia for some time, but prior to Samuel’s prototype there were no plant-based wigs produced anywhere – and no widely available vegan-friendly options produced in the UK. 

“As a vegan, I oppose all forms of animal exploitation, from gratuitous cruelty like bull fighting or fox hunting, to the industrial-scale cruelty of factory farming, to more subtle forms of cruelty which nevertheless involve the ownership and commodification of animal bodies,” commented Samuel.

“For me, horsehair is at the latter end. Of course, it is conceivable that there are ways this could be taken without immediate physical pain, but that does not mean it is not exploitation.”

He continued: “I refuse to sponsor exploitation by buying expensive items made from animal products as this adds value to the practice of owning them and selling them for parts.”

Hemp, a native, natural fibre is coming back into use in the modern world as society turns its attention to protecting the planet.

Around 100 years ago, industrial hemp was used to help the British army compete in the world wars, making sails and ropes for their ships. 

There were rope manufacturers, clothes makers and industrial hemp grown all around the UK to supply this demand. 

After revealing of the product, Laura Bossom, founder of the hemp manufacturer, Cultiva Kingdom, said: “It is exciting to see how we have brought this material back to life, applying it to a product which will be showcased in a legal setting and can make a contribution to environmental objectives”

Recently government legislation around the world has set new net zero carbon targets and the UK plans to see all green-house gases to net zero by 2050.

As hemp can absorb four times as much carbon than the average plant, the wig can off-set carbon dioxide as its raw materials are grown. 

In addition, the bioremediation crop only requires one third of the water than cotton which reduces its impact on water resources and land degradation. 

This is imperative if we wish to see depleted soils recover from intensive farming practices which have been carried out for centuries. 

Samuel’s wig has received a positive response from the legal industry. 

Within 48 hours of unveiling his idea, he had received over 30 order requests. 

The wig has been estimated to retail at £650, which puts it in a high-tier bracket next to traditional horse-hair wigs sold at £400 and £700. 

And Ivy & Normanton, the UK’s first legal outfitter for women has already shown an interest in stocking the product. 

Karlia Lykourgou, founder of Ivy & Normanton and practicing criminal barrister at Doughty Street Chambers, said: “There’s definitely a positive conversation to be had and we are interested. 

“I’ve actually been shown a synthetic wig and it does not have the same quality as a horsehair wig. The legal garb that we wear is significant and it means something. 

“We do not want to dilute the quality of this garb that we wear, it’s a sacred uniform and it takes a lot to get there. A hemp wig sounds like it might have a similar quality to horsehair, there’s certainly a conversation to be had.” 

The product has also caught the attention of Labour’s Shadow Minister for Legal Aid, Karl Turner, who described it as a “brilliant idea”. 

Miranda Moore QC, one of the heads of Chambers at 5 Paper Building said: “Sam is fully supported by Chambers, as I made clear to him when he first mentioned the idea to me some months ago. 

“I am generally supportive of the practice of wearing wigs, but consider that appropriate court attire should be inclusive and what it is made out of is immaterial. 

“People should be able to express themselves in line with their values, whether that means a Sikh being able to wear a turban instead of a wig or a vegan going out and sourcing something suitable.” 

News

Ireland to fund patient’s medical cannabis up front

Campaigner Vera Twomey described “relief” that her determination has finally paid off.

Published

on

Ava Barry medical cannabis patient
Vera Twomey's daughter, Ava Barry has a severe from of epilepsy which is helped by medical cannabis

Campaigner Vera Twomey has described her “relief” as the Irish Government agrees to fund medical cannabis patient’s prescriptions up front.

Eligible medical cannabis patients in Ireland will now have their medication paid for up front, after months of pressure on the Government from campaigners. 

Health Minister Stephen Donnelly announced on Monday 19 July that the refund system for patients who obtain their prescribed cannabis-based products from the Netherlands, will now be replaced by a direct payment system.

The HSE will pay the dispensing pharmacy in the Netherlands directly, rather than the burden falling to the patients and their families, who were then required to apply for a refund.

Vera Twomey, whose daughter Ava Barry, 11, has a severe form of epilepsy known as Dravet syndrome, is among 40 patients who have now been granted an individual ministerial licence to import Bedrocan oil to Ireland.

But the family were paying 10,000 Euros up front every three months for Ava’s prescription and waiting up to five weeks for it to be refunded.

Campaigner Vera Twomey is “delighted” by the news

Twomey, who has four other children, has previously spoken of the huge financial strain this system placed on her family.

Over the last 16 months she has relentlessly called for action, making dozens of phone calls daily to politicians and lobbying ministers on social media with the backing of thousands of supporters in Ireland and across the world.

Twomey, who received a phone call from Ireland’s Prime Minister, Micheál Martin on Monday confirming the news, says she is “delighted” that her determination has finally paid off.

“There’s a sense of relief that we have accomplished this, but also a little bit of shock because we have been trying to resolve it for so long,” she told Cannabis Health.

Twomey’s activism gained national attention in 2017 when she walked from her home in Cork to Leinster House in Dublin to ask former Health Minister Simon Harris to grant access to medical cannabis for her daughter. 

Initially having to travel to the Netherlands to collect the prescription herself, during the pandemic Twomey successfully campaigned to secure the permanent delivery of Bedrocan oils for Ava and other patients.

Now she says she is looking forward to focusing on her family and putting the phone down for a while.

“I don’t think anybody who has gone through this fight, seeing the injustice that we have had to deal with could ever walk away,” she said.

“But at the same time, I’ve made a lot of sacrifices and for the moment at least, I need to give 100 percent to my other children, to do normal things and be a family.”

But the fight in Ireland isn’t over.

The Irish Government announced the provision of funding for the Medical Cannabis Access Programme (MCAP) in January – almost two years after it was introduced – but only four low dose cannabis-based medicines are covered by the programme, for people living with one of three qualifying conditions.

“There are other issues – we still need expansion and improvement in medical cannabis access, the journey is over by any means, but we’re at the beginning and getting Bedrocan recognised as a medicine that is funded up front is very important.

“I think the Irish are actually miles ahead of the British on this one and I hope [politicians] will take notice and catch up.” 

She added: “The greatest gift you’ll ever receive is to lose your fear, then you can accomplish anything with focus and determination.

“If you have the determination to keep going you will get there. It’s not going to be easy, they are not going to make it easy but it can be done.”

Patients eligible for the direct payment system are those suffering from one of three stated conditions; spasticity associated with multiple sclerosis, intractable nausea and vomiting associated with chemotherapy and severe, refractory (treatment-resistant) epilepsy. 

The HSE says it will be contacting patients directly.

Health Minister, Mr Donnelly, commented: “I am delighted that the HSE and Transvaal Apotheek in the Netherlands are implementing a new process which will give peace of mind to the seventeen patients and their families who until now have been using the refund process.”

 

 

 

 

Continue Reading

Industry

Kanabo’s cannabis vaporiser for metered dosing launches in UK

The VapePod will give thousands of UK patients access to pain relief in a metered dose.

Published

on

Kanabo cannabis Vapepod
The VapePod can administer a measured dose of cannabis extract

Cannabis company Kanabo’s new extract formula and vaporiser will give thousands of UK patients access to pain relief in a metered dose.

UK patients will be the first in Europe to have access to Kanabo’s vaporiser, the VapePod, and its new extract formula when is it delivered later this month.

The deal, in conjunction with LYPHE Group, will see patient’s of LYPHE Group’s ecosystem, including The Medical Cannabis Clinic and Dispensary Green, able to access the VapePod under the brand name NOIDECS.

Under the agreement, PharmaCann and Kanabo established a customised production line for Kanabo’s VapePods cartridges.

An alternative to cannabis flower

The VapePod is a medical-grade, handheld vaporiser which enables accurate and precise micro doses of cannabis extract, dispensing 1mg of formula for each inhalation.

This will benefit to patients as inhaling extracts rather than tinctures and oils allows for faster onset and higher bioavailability.

It will also allow clinicians to more confidently prescribe and monitor a patient’s dosage, as well as providing more accurate patient data.

Previously, cannabis patients in the UK have only been able to access medical cannabis dry flower and oil tinctures for which the majority of patients consume via inhalation due to fast onset time.

Kanabo’s medical line aims to enable patients to move away from the harmful act of smoking medical cannabis flowers as they can now take their medicine without inhaling soot, tar and carcinogens into the lungs.

Kanabo founder, Avihu Tamir

Avihu Tamir, Kanabo’s CEO, said: “The VapePod is a world first allowing specialist consultants to prescribe a metered dose of medicinal cannabis that is healthier for patients than the alternative, which is typically smoking.

“Medical cannabis is a safer alternative to the conventional opiate solutions and other pain management treatments. This announcement ensures that thousands of UK patients have access to the most effective medicinal cannabis delivery system.

“The fact that the VapePod gives exactly 1mg on every inhalation is crucial for GPs because they can prescribe an exact dose which they haven’t been able to do before. For patients who want the similarity to smoking but know they are not inhaling soot and tar. There’s also the bioavailability factor too.

“The reason GPs haven’t been prescribing is the issue of dosing and flowers – they don’t feel comfortable asking patients to smoke. With Kanabo, they can prescribe exact dosing in a safe and consistent way.”

The medical extract formula, which is based on the Israeli medical cannabis pharmacopoeia as a recommendation for the treatment of pain management, has a purity of 70 percent THC with 15 percent minor cannabinoids and terpenes.

Earlier this year Kanabo became the second cannabis company to list on the London Stock Exchange.

Dean Friday, LYPHE’s CEO commented: “Kanabo are experts in novel delivery with their VapePod greatly improving onset times, and for our chronic pain patients we now have an alternative to flower vaporisation. This is the start of a revolution in medical cannabis application and we are delighted to be supplying it under the NOIDECS brand.”

 

 

Continue Reading

Mental health

Cancer survivors turn to cannabis for physical and mental health – study

Cancer survivors are more likely to use cannabis to help pain, anxiety, sleep and nausea. 

Published

on

cancer
Cancer survivors are more likely to use cannabis to help pain, anxiety, sleep and nausea. 

Cancer survivors are frequently using cannabis to manage physical and mental health symptoms, says a new study.

Research from the US indicates that cancer survivors are more likely to use cannabis for symptoms such as pain, anxiety, trouble sleeping and nausea. 

A team of investigators analysed results from a Covid-19 cannabis health study to examine changes to cannabis use, methods of cannabis delivery, and coping strategies among cancer survivors since the pandemic.

They found that individuals with a history of cancer are more likely to report cannabis use to manage mental health and pain symptoms.

This group of people were also more likely to report fear of a Covid-19 diagnosis, compared to adults without a history of cancer.

Data was collected from 158 responses between 21 March 2020 and 23 March 2021, from cancer survivors who identified as medicinal cannabis users.

These were then compared to medicinal cannabis users without a history of cancer of the same age.

According to the study, cancer survivors were more likely to report using cannabis as a way of managing nausea/vomiting, headaches or migraines, seizures, sleep problems or as an appetite stimulant.

Specifically, self-reported symptoms most frequently managed by medicinal cannabis among respondents included anxiety and pain. 

Sixty one percent of respondents with a history of cancer used cannabis to manage anxiety symptoms and 54 percent for chronic pain.

Forty eight percent said they used it to manage depressive symptoms and 25 percent for PTSD, while smaller numbers used it for symptoms of another autoimmune disease, and irritable bowel syndrome. 

While there were no differences in how often they used cannabis or their method of administration, cancer survivors were “more likely to have an advanced supply of cannabis”. 

The findings support the need for more conversations between doctors and their patients about the use of cannabis, say those behind the study.

The authors concluded: “Overall, we observed that cancer survivors are frequently reporting the use of cannabis to manage both physical and mental health symptoms associated with their cancer diagnosis and that cancer survivors are more likely to report fear of a Covid-19 diagnosis compared to those without a history of cancer. 

“Given the frequency of mental and physical health symptoms reported among cancer survivors during the Covid-19 pandemic period, clinician–patient interactions should include questions around cannabis use, particularly those with a history of cancer.”

Continue Reading

Trending